.svg){kind=small}
Jun-2026
Sales
Trend
6-Month
Product Count
SKUs
Avg Price
YoY Sales Change
YoY Price Change
Market Insights Snapshot
Kaizen Medicinals concentrated its June 2026 revenue in Concentrates at 86.63% share with 253.83% year-over-year growth and 69.85% month-over-month expansion, while Vapor Pens held 12.90% share with a 93.62% month-over-month lift and no year-over-year baseline. Flower contracted to 0.48% share with a -61.32% month-over-month change, and the brand’s overall average price in June 2026 was up 0.97% year over year to $17.46. With Concentrates anchoring the mix and Vapor Pens accelerating sequentially, the pattern implies Kaizen Medicinals is compounding depth in a single lead category while selectively incubating a second pillar rather than pursuing a broad assortment.
Within Concentrates, Kaizen Medicinals sat at rank 30 in California, and the category’s 86.63% share alongside a 69.85% month-over-month gain signals share-of-effort concentration as opposed to price-led expansion, given the 0.97% year-over-year price move. Vapor Pens’ 93.62% month-over-month rise against a 12.90% share suggests a fast-follower posture that can lift visibility without diluting the Concentrates position, while Flower’s -61.32% month-over-month decline at 0.48% share indicates purposeful de-emphasis of low-yield SKUs; taken together, the mix points to a focused-ladder strategy aimed at climbing category rank in California before broadening the portfolio breadth.
Competitive Landscape
Kaizen Medicinals sits at rank #30 in CA Concentrates in June 2026, improving 50 positions from #80 year over year and climbing 17 spots from #47 in March 2026; this is also a peak rank of #30 in June 2026. In contrast, Raw Garden held steady at #1 year over year with a 7.0% YoY sales increase, while 710 Labs moved up from #4 to #3 alongside a 24.7% YoY sales rise, indicating Kaizen Medicinals’ rank gains are occurring while leaders consolidate top positions. The juxtaposition of a #30 peak and a 50-rank YoY ascent implies Kaizen Medicinals is transitioning from fringe presence to mid-pack relevance, with further gains likely contingent on converting momentum into sustained share against entrenched top-5 competitors.
Notable Products
Golden Tropic Live Resin Badder (1g) posted the largest month-over-month surge at 557%, vaulting into rank 3 in June 2026, while Blue Banana Dream Live Resin Badder (1g) climbed 313% to rank 1. Lemon Reactor Live Resin Badder (1g) added 167% and reached rank 2, and Forbidden Zkittlez Live Resin Badder (1g) advanced 21% but held outside the top five at rank 7. Six of the top ten are Concentrates Live Resin Badder SKUs, indicating a concentrated push toward terpene-forward extracts. This pattern implies Kaizen Medicinals is consolidating around high-velocity badder formats to build share at the top of the lineup.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.
